Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Liviero (Padova, Italy), M. Scarpa (Padova, Italy), P. Mason (Padova, Italy), G. Guarnieri (Padova, Italy), P. Maestrelli (Padova, Italy). Modulation of Transient Receptor Potential Vanilloid-1 (TRPV1) response by inhaled prostaglandin-E2 and bradykinin. 3561

Member's Comments

No comment yet.

Related content which might interest you: Modulation of transient receptor potential vanilloid-1 (TRPV1) by inhaled prostaglandin-E2 (PGE2) and bradykinin (BK) is associated with increased cough sensitivity to capsaicin (CPS) and autonomic dysregulation of cardiac rhythm in healthy subjects Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Investigating Transient Receptor Potential V4 channel induced bronchospasm Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha Source: International Congress 2018 – Basic pharmacology Year: 2018 Extracellular ATP is a danger signal activating P2X7 Receptor in a LPS mediated inflammation (ARDS/ALI) Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 Loss of the calcium-sensing receptor (CaSR) decreases slowly-adapting receptor responsiveness to mechanical stretch independent of oxygenation status Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Protease-activated receptor 2 (PAR2) stimulation potentiates citric acid induced cough by sensitising the vanilloid receptor-1 (TRPV1) Source: Annual Congress 2003 - Novel drugs under development for the treatment of respiratory diseases Year: 2003 Inhibition of basophil activation by adenosine and its agonists Source: Eur Respir J 2001; 18: Suppl. 33, 532s Year: 2001 Down-regulation of allergic reactions by stimulation of prostaglandin E receptor EP3 subtype Source: Annual Congress 2004 - Insights into asthma and COPD Year: 2004 Inhaled corticosteroids and leukotriene receptor antagonists induce protection against adenosine 5‘monophosphate induced bronchospasm in a synergic fashion Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 The effect of leukotrienes and their receptor antagonists on calcium signalling in the cough receptors transient receptor potential ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1) Source: Annual Congress 2010 - Models of airways disease Year: 2010 TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cAMP in human macrophages Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Suppression of basophil activation via histamine receptor 2 (HR2) Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005 Effect of an inhaled adenosine A2A agonist on the allergen induced late asthmatic response Source: Eur Respir J 2003; 22: Suppl. 45, 204s Year: 2003 Effect of long-acting β2 adrenergic receptor agonists and glucocorticoids on extracellular matrix production Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001 Characterization of toll-like receptor 7 (TLR7) expression on airway nerves Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019